UnknownNot Applicable

Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal Syndrome

Taiwan30 participantsStarted 2021-07-01

Plain-language summary

This project is to understand the LTBP4 expression in human renal fibrotic tissues. The investigators will exam major location of LTBP4 expression and check any similar or discrepancy in renal fibrosis with different etiologies.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Abnormal kidney function, proteinuria, hematuria Exclusion Criteria: * N/A

What they're measuring

Expression of LTBP4 in human renal fibrotic tissue

Timeframe: 5 years

Expression of biomarkers in human renal fibrotic tissue

Timeframe: 5 years

Trial details

NCT IDNCT05012228

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-01

Contact for this trial

Chi-Ting Su, MD, MPH, PhD

+88697262878 A01218@ntucc.gov.tw

View on ClinicalTrials.gov More Renal Fibrosis, CKD trials